Project Nephron
End-Stage Renal Disease (ESRD) requiring hemodialysis
Pre-clinicalActive
Key Facts
Indication
End-Stage Renal Disease (ESRD) requiring hemodialysis
Phase
Pre-clinical
Status
Active
Company
About Nephria Bio
Nephria Bio is an early-stage biotech/medtech company developing Project Nephron, a wearable, portable artificial kidney system designed to transform hemodialysis treatment. The device aims to free patients from stationary clinic sessions by offering a lightweight, discreet wearable with features like dialysate recycling, remote patient monitoring, and AI-driven personalized therapy. Targeting the large and costly ESRD market, the company's value proposition centers on patient quality of life, potential clinical improvements via continuous therapy, and operational efficiencies for the healthcare system.
View full company profile